Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf-Henning Boehncke

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Efalizumab in the treatment of psoriasisWolf-Henning Boehncke
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2025
When TNF-α becomes a matter of the heartWolf-Henning Boehncke
Rheumatic Diseases Clinics of North America|October 18, 2015
Etiology and Pathogenesis of PsoriasisWolf-Henning Boehncke
Nature|December 21, 2012
Perspective: Don't be superficialWolf-Henning Boehncke
Revue Medicale Suisse|March 28, 2019
Wolf-Henning Boehncke
The Journal of Rheumatology|June 3, 2014
GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoringWolf-Henning Boehncke
The Journal of Rheumatology|February 3, 2012
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meetingWolf-Henning Boehncke
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
"Evergreen" Psoriasis - Neues zu Genetik, Therapie, und überhauptWolf-Henning Boehncke
European Journal of Dermatology : EJD|July 13, 2004
The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skinWolf-Henning Boehncke
Frontiers in Immunology|April 21, 2018
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and ConsequencesWolf-Henning Boehncke
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Biologics : Targets & Therapy|August 27, 2009
Efalizumab in the treatment of psoriasisWolf-Henning Boehncke
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2025
When TNF-α becomes a matter of the heartWolf-Henning Boehncke
Rheumatic Diseases Clinics of North America|October 18, 2015
Etiology and Pathogenesis of PsoriasisWolf-Henning Boehncke
Nature|December 21, 2012
Perspective: Don't be superficialWolf-Henning Boehncke
Revue Medicale Suisse|March 28, 2019
Wolf-Henning Boehncke
The Journal of Rheumatology|June 3, 2014
GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoringWolf-Henning Boehncke
The Journal of Rheumatology|February 3, 2012
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meetingWolf-Henning Boehncke
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
"Evergreen" Psoriasis - Neues zu Genetik, Therapie, und überhauptWolf-Henning Boehncke
European Journal of Dermatology : EJD|July 13, 2004
The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skinWolf-Henning Boehncke
Frontiers in Immunology|April 21, 2018
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and ConsequencesWolf-Henning Boehncke
Pageof 25